This showed that post CF but not control plasma led to a dose‐dependent increase chemotaxis toward a VEGF gradient of CAC from both CAD patients and healthy volunteers (Figure 9C, p interaction dosexintervention<0.001, p interaction dosexinterventionxgroup = 0.417). The gene discussed is VEGFA; the disease is coronary artery disorder.